Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Generalized Anxiety Disorder

In brief

The purpose of this study is to learn about the safety and efficacy of pexacerfont in outpatients diagnosed with Generalized Anxiety Disorder

Key facts

Study ID

NCT00481325

Run by

Bristol-Myers Squibb

People needed

260

Starts

2007-07-01

Expected to finish

2008-03-01

Last updated by the study team

2015-10-12

Who can join

Age: 18 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Outpatient women ages 18-65 meeting Diagnostic and Statistical Manual of Mental Disorders Manual, Fourth Edition, Text Revision (DSM-IV TR) criteria for Generalized Anxiety Disorder (GAD), either moderate or severe (300.02)

You may not qualify if…

• Males
• Patients who report a history of inadequate response to three or more adequate trials of any selective Serotonin reuptake inhibitors (SSRIs) for GAD within the last three years

Where it is running

• Pacific Clinical Research Medical Group — Burbank, California, United States
• Us Clinical Research Centers, Llc — Costa Mesa, California, United States
• Pacific Institute For Medical Research, Inc. — Los Angeles, California, United States
• Affiliated Research Institute — San Diego, California, United States
• Pacific Clinical Research Medical Group — Upland, California, United States
• Radiant Research, Inc. — Denver, Colorado, United States
• University Of Connecticut Health Center — Farmington, Connecticut, United States
• Comprehensive Psychiatric Care, Pc — Norwich, Connecticut, United States
• Meridien Research — Brooksville, Florida, United States
• Clinical Neuroscience Solutions — Jacksonville, Florida, United States
• Comprehensive Neuroscience, Inc. — St. Petersburg, Florida, United States
• Stedman Clinical Trials — Tampa, Florida, United States
• Janus Center For Psychiatric Research — West Palm Beach, Florida, United States
• Carman Research — Smyrna, Georgia, United States
• Indiana University School Of Medicine — Indianapolis, Indiana, United States
• Alpine Clinic — Lafayette, Indiana, United States
• Cientifica, Inc. At Prairie View Inc. — Newton, Kansas, United States
• Ctt, Inc. — Prairie Village, Kansas, United States
• J. Gary Booker, Md, Apmc — Shreveport, Louisiana, United States
• Pharmasite Research, Inc. — Baltimore, Maryland, United States
• Capital Clinical Research Associates — Rockville, Maryland, United States
• Boston Clinical Trials, Inc. — Boston, Massachusetts, United States
• Regions Hospital — Saint Paul, Minnesota, United States
• Neurobehavioral Research, Inc. — Cedarhurst, New York, United States
• Pivotal Research Centers — Mesa, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.